Vizsgálati helyszín
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)
- 72futó vizsgálat
- 5lezárt vizsgálat
- 0a helyszín által az elmúlt 60 napban megerősített vizsgálat
- –nyelv nincs megadva
A helyszín még egy vizsgálatot sem erősített meg.
Futó vizsgálatok
Még nem toboroz
A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate
Toboroz
A Study of Ropeg-Interferon in People With Polycythemia Vera
Toboroz
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
Toboroz
Radiation Therapy Approaches for People With Prostate Cancer
Toboroz
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
Toboroz
A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
Toboroz
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Toboroz
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
Toboroz
Toboroz
Toboroz
Toboroz
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
Fut, nem toboroz
A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer
Toboroz
Toboroz
Toboroz
Toboroz
Toboroz
A Study of Surgery and Radiotherapy in People With Breast Cancer
Toboroz
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Toboroz
Toboroz
Toboroz
Toboroz
A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
Toboroz
Toboroz
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
Toboroz
A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
Toboroz
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
Toboroz
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
Toboroz
Fut, nem toboroz
A Study of a Pelvic Floor Muscle Exercise Program Before and After Radical Prostatectomy
Toboroz
A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
Toboroz
Toboroz
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
Toboroz
A Study of Sotorasib in People With Non-Small Cell Lung Cancer
Toboroz
Toboroz
Toboroz
Toboroz
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer
Fut, nem toboroz
Toboroz
A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
Fut, nem toboroz
Fut, nem toboroz
A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma
Fut, nem toboroz
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
Toboroz
Toboroz
Toboroz
Toboroz
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Toboroz
Toboroz
Meghívásos bevonás
Improving Surgeon Performance Measures for Robot-Assisted Surgery
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
- Tüdőrák9 toboroz
- Mielóma multiplex6 toboroz
- Prosztatarák6 toboroz
- Áttétes emlőrák5 toboroz
- Fej-nyaki daganatok5 toboroz
- Szarkóma5 toboroz
- Gyermekkori daganatok3 toboroz
- Hasnyálmirigyrák3 toboroz
- Akut mieloid leukémia (AML)2 toboroz
- Glioblasztóma2 toboroz
- Hólyagrák2 toboroz
- Melanóma2 toboroz
- Mieloproliferatív neopláziák2 toboroz
- Tripla negatív emlőrák2 toboroz
- Vastagbélrák2 toboroz
- Vesedaganat2 toboroz
- Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
- Follikuláris limfóma1 toboroz
- Mezotelióma1 toboroz
- Neuroendokrin daganatok1 toboroz
- Petefészekrák1 toboroz
Kutatók
Ide még nem kötődik kutató.
Lezárt vizsgálatok
Visszavonták
A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer
Visszavonták
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
Leállították
Lezárult
A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)
Lezárult
Helyszínadatok: ClinicalTrials.govFrissítve: 2026. nov. 7.